Clinical Trial

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Nonalcoholic fatty liver disease (NAFLD) is the most common type of liver disease in the United States. The incidence of NAFLD is very similar to that of obesity, type 2 diabetes, and the metabolic syndrome. The investigators hypothesize that there may be a relationship between over-nutrition, decreased physical activity and the development of fatty liver. The purpose of this study is to identify the types of fats and proteins, and the quantity of each, that are associated with increased severity of NAFLD.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2009-09-23; most recent amendment 2025-12-09.
Trial Details
NCT Number NCT00983463
Lead Sponsor Vanderbilt University
Conditions Nonalcoholic Fatty Liver Disease
Enrollment 45 participants
Start Date 2009-10
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-12-18